Fund Holdings — Sarissa Capital Management LP

Total Portfolio Value:
$154.71M
Total Bought:
$4.12M
Total Sold:
$114.84M
Net Transaction:
-$110.72M
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Innoviva, Inc.(INVA)7,277,0002,816,022-4,460,978$126.26M$51.05M33.00%-$75.20M
Neurocrine Biosciences, Inc.(NBIX)309,116309,1160$42.19M$34.19M22.10%-$8.01M
Cytokinetics, Incorporated(CYTK)833,799600,000-233,799$39.22M$24.11M15.59%-$15.11M
Ironwood Pharmaceuticals, Inc.CL A(IRWD)16,390,00016,390,0000$72.61M$24.09M15.57%-$48.51M
Amarin Corp PlcADR24,850,62324,850,6230$12.05M$11.14M7.20%-$917.0K
Lantheus Holdings, Inc.(LNTH)63,000100,000+37,000$5.64M$9.76M6.31%+$4.12M
Vor Biopharma Inc.(VOR)618,000508,016-109,984$686.0K$364.5K0.24%-$321.5K
Gilead Sciences, Inc.(GILD)262,0800-262,080$24.21M$0—-$24.21M
Page 1 of 1